SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001689813-20-000027
Filing Date
2020-03-20
Accepted
2020-03-20 16:44:50
Documents
5
Period of Report
2020-04-30
Effectiveness Date
2020-03-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2020bhvndef14aproxystatem.htm DEF 14A 801761
2 GRAPHIC bhvn2020pcpg1.jpg GRAPHIC 230961
3 GRAPHIC bhvn2020pcpg2.jpg GRAPHIC 222527
4 GRAPHIC bhvn2979219215221a01.jpg GRAPHIC 84292
5 GRAPHIC bhvnlogo2020proxy.jpg GRAPHIC 19308
  Complete submission text file 0001689813-20-000027.txt   1569972
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38080 | Film No.: 20732486
SIC: 2834 Pharmaceutical Preparations